Literature DB >> 30859486

YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells.

Filiz Kisaayak Collak1, Ummuhan Demir2, Fatma Sagir2.   

Abstract

The Yes Associated Protein 1 (YAP1) is a transcriptional cofactor negatively regulated by Hippo Pathway. The dysregulation of the pathway has been shown to have a role in tumorigenesis and metastasis in several cancers including prostate cancer (PCa). In this study, YAP1 expression was upregulated in the whole cell lysates and cytoplasmic/nuclear extracts of AR negative (PC3) compared to AR positive (LNCaP) prostate cancer cell lines and primary prostate epithelial cells (PrePEC). pYAP1 expression elevated in LNCaP compared to PC3 and PrePEC in whole cell lysates and cytoplasmic extracts. The treatment of LNCaP and PC3 with YAP1-targeting siRNA oligonucleotides (YAP1 siRNA) significantly reduced their proliferation in vitro. Furthermore, treatment with YAP1 siRNA diminished the clonogenicity, anchorage-independent growth on soft agar, migration and invasion of PC3 cells. Co-IP/WB experiments revealed that YAP1 and AR formed a complex and ChIP/PCR results confirmed that YAP1 was bound to androgen response elements (ARE) core region of the prostate specific antigen (PSA) promoter. The loss of function experiments in LNCaP and PC3 revealed that YAP1 regulates proliferation, colony formation as well as anchorage-independent growth and potentially plays an important role in migration and invasion. Finally, analysis of publicly available data sets indicated that LNCaP had no YAP1 copy number alteration whereas PC3 had gain of YAP1 which was also reflected as an increase in the mRNA level. Moreover, YAP1 copy number gain and elevated YAP1 mRNA expression were detected in clinical samples analyzed in publicly available data sets. Taken together, these results suggested that YAP1 has a role in PCa tumorigenesis.

Entities:  

Keywords:  Androgen receptor; Prostate cancer; YAP1; pYAP1

Mesh:

Substances:

Year:  2019        PMID: 30859486     DOI: 10.1007/s12253-019-00634-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  7 in total

1.  HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation.

Authors:  Junyu Chen; Duo Xu; Taiwei Wang; Zhaoyun Yang; Yanrong Yang; Kang He; Lijing Zhao
Journal:  Oncol Rep       Date:  2022-09-21       Impact factor: 4.136

Review 2.  The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?

Authors:  Carole Luthold; Tarek Hallal; David P Labbé; François Bordeleau
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

3.  Long Noncoding RNA MALAT1 Promotes Laryngocarcinoma Development by Targeting miR-708-5p/BRD4 Axis to Regulate YAP1-Mediated Epithelial-Mesenchymal Transition.

Authors:  Xiaoqin Wu; Yenong Tan; Xuxia Tang
Journal:  Biomed Res Int       Date:  2022-05-12       Impact factor: 3.246

4.  BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming.

Authors:  Yuan-Yuan Chen; Wei-Hua Wang; Lin Che; You Lan; Li-Yin Zhang; Deng-Lin Zhan; Zi-Yan Huang; Zhong-Ning Lin; Yu-Chun Lin
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639

Review 5.  Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer.

Authors:  Ioanna Mourkioti; Andriani Angelopoulou; Konstantinos Belogiannis; Nefeli Lagopati; Spyridon Potamianos; Efthymios Kyrodimos; Vassilis Gorgoulis; Angelos Papaspyropoulos
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

6.  Pathological significance and prognostic role of LATS2 in prostate cancer.

Authors:  Tsuyoshi Matsuda; Yasuyoshi Miyata; Yuichiro Nakamura; Asato Otsubo; Yuta Mukae; Junki Harada; Kensuke Mitsunari; Tomohiro Matsuo; Kojiro Ohba; Bungo Furusato; Hideki Sakai
Journal:  Prostate       Date:  2021-09-07       Impact factor: 4.012

Review 7.  The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

Authors:  Tanzila Khan; Kieran F Scott; Therese M Becker; John Lock; Mohammed Nimir; Yafeng Ma; Paul de Souza
Journal:  Prostate Cancer       Date:  2020-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.